XM does not provide services to residents of the United States of America.

Sonova lags half-year profit estimates due to product launch costs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-Sonova lags half-year profit estimates due to product launch costs</title></head><body>

Corrects to EBITA, not EBITDA, in paragraph 9

By Amir Orusov and Anastasiia Kozlova

Nov 19 (Reuters) -Swiss hearing aid maker Sonova Holding SOON.S reported half-year core earnings below market expectations on Tuesday, weighed down by costs related to the launch of its new AI-boosted hearing device.

The world's largest maker of hearing aids said its adjusted earnings before interest, tax and amortisation (EBITA) fell 3.7% in local currencies to 325.2 million Swiss francs ($368.1 million) in the six months through September. Analysts polled by Vara were expecting 341.3 million on average.

It reaffirmed its full-year targets and said its profitability should grow significantly in the second half of the year, driven by stronger sales momentum, higher average selling prices and launch costs winding down.

Sonova gained an edge over its peers in August when it launched a first-in-market hearing aid utilising real-time AI, as tech-driven competition intensifies in the sector.

Since its launch, the new product made up more than 50% of units sold under the Infinio brand, the company said.

Vontobel analysts have said they expect Sonova's peers to launch improved AI devices by the end of 2025, but until then Sonova should be able to increase its sales and regain market share.

The launch of the new hearing aid family and its reported return as a Costco supplier have helped Sonova's shares to outperform peers like Denmark's GN Store Nord GN.CO and Italy's Amplifon AMPF.MI this year.

However, its results have been dented by strong gains of the Swiss franc against other currencies, including euro and U.S. dollar. Sonova makes around 80% of its sales in the Europe, Middle East and Africa (EMEA) region and the United States.

Based on Swiss franc reporting, its adjusted EBITAfell 7.1% in the first half of the year.

($1 = 0.8834 Swiss francs)



Reporting by Amir Orusov and Anastasiia Kozlova in Gdansk; editing by Milla Nissi

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.